glp 1 alzheimer's trial Could diabetes and weight loss drugs treat disease? Novo Nordisk justifies reasoning behind

Patients on GLP-1 injections can lose 15 to 20 percent of their body weight over 12 to 18 months

Explore how GLP-1s and peptides break plateaus, reduce appetite, and support fat loss

Take a look at this email from Noom with the subject line: GLP-1s spark change

GLP1 MASLD MASH treatment offers dual benefits for liver and metabolic health in people with type 2 diabetes or obesity

Learn about the latest science behind GLP-1 weight loss drugs, the nutritional needs of GLP-1 users and what this means for future innovation in food and beverage.

At your in-person assessment, you and your provider will determine the most appropriate tier